Global Atherosclerosis Market Industry Segments, Current and Future Trends, Share Till 2026 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Share
Jammu: In what could be the game changer for the development of health care services in the Union territory of Jammu and Kashmir, more than 22000 free and cashless treatments have been provided to eligible beneficiaries under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) SEHAT scheme in the first two months.
The scheme was launched by Prime Minister on 26th December 2020 and it aims to provide Universal Health Insurance Coverage of Rs. 5.00 lakh per family on a floater basis in convergence with central government’s Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY).
Since the launch of the scheme, more than 30 Lakh residents of Jammu and Kashmir have already registered under the scheme, covering about 56% of the families. Under the scheme, in the first two months, 22.05 Lakh Golden cards have been issued to eligible beneficiaries in addition to 13.28 Lakh Golden Cards already issued under AB PM-JAY. Under AB PM-JAY, about 70% of the eligible fam
JK Admin Issues 22 Lakh Golden Cards Of Health Insurance Scheme Within Two Months
SRINAGAR: In what could be the game-changer for the development of health care services in the Union territory of Jammu and Kashmir, more than 22000 free and cashless treatments have been provided to eligible beneficiaries under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) SEHAT scheme in the first two months.
The scheme was launched by Prime Minister on December 26, 2020 and it aims to provide Universal Health Insurance Coverage of Rs. 5.00 lakh per family on a floater basis in convergence with central government’s Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY).
Study suggests women undergo less aggressive open heart surgery ANI | Updated: Feb 06, 2021 14:32 IST
Washington [US], February 6 (ANI): Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using guideline-recommended approaches, which may result in worse outcomes after surgery, as per a new study.
The results of the study were published in the journal The Annals of Thoracic Surgery . The study was presented at the 57th Annual Meeting of The Society of Thoracic Surgeons. This study highlights key differences between women and men in surgical techniques used for CABG and reveals opportunities to improve outcomes in women, said Oliver K. Jawitz, MD, from Duke University in Durham, North Carolina.
11 gennaio 2021 | 11.34 LETTURA: 5 minuti
DuraGraft is a one-time intraoperative treatment used during vascular surgery to reduce the incidence of complications associated with graft failure
JUPITER, Fla., Jan. 11, 2021 /PRNewswire/ Marizyme, Inc. (OTCQB: MRZM), a global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, today announced as of August 2020 the Vienna Heart Center North Floridsdorf of Vienna, Austria was the first clinic worldwide to use the company s flagship product, DuraGraft® as the standard-of-care for flushing and storage of the saphenous vein grafts from harvesting through grafting in Coronary Artery Bypass Grafting (CABG) patients.